Autoimmune Disease Diagnostics Market 2025-2029 The autoimmune disease diagnostics market is forecasted to grow by USD 3494.8 mn during 2024-2029, accelerating at a CAGR of 10.2% during the forecast period. The report on the autoimmune disease diagnostics market provides a holistic analysis, market ...

Veterinary Autoimmune Disease Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on veterinary autoimmune disease therapeutics market which i ...

Kentley Insights’ 2025 Blood & AutoImmune Diseases Global Market Size & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with foreca ...

Acquired (Autoimmune) Hemolytic Anemia - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Acquired (Autoimmune) Hemolytic Anemia - Global Clinical Trials Review, 2025 provides an overview of Acquired (Autoimmune) Hemolytic Anemia Clinical trials scenario. This report ...

The lupus nephritis treatment market size was valued at USD 1.80 Billion in 2024, driven by the emphasis on preventing kidney failures. The market is expected to grow at a CAGR of 7.50% during the forecast period of 2025-2034, with the values likely to reach USD 3.71 Billion by 2034. Lupus Nephritis ...

Global Cold Agglutinin Disease Market, Analysis and Forecast: 2025-2035 The global cold agglutinin disease (CAD) market is experiencing gradual, significant growth, driven by increasing awareness of the condition, advancements in diagnostic and therapeutic technologies, and improved access to specia ...

Global MHC-Peptide Tetramer market size in terms of revenue is projected to reach 382.44 million USD by 2031 from 194.40 million USD in 2024, with a CAGR 10.50% during 2025-2031. North America market for MHC-Peptide Tetramer is estimated to increase from 63.45 million USD in 2024 to reach 116.42 mil ...

This study covers the world outlook for primary immunodeficiency disease tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...

This study covers the world outlook for systemic Lupus erythematosus across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for primary immunodeficiency diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ...

This study covers the world outlook for primary immunodeficiency across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for plasma fractionation of intravenous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ...

This study covers the world outlook for subcutaneous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for therapeutic plasma exchange for neurological disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the pe ...

This study covers the world outlook for progressive multifocal leukoencephalopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ...

This study covers the world outlook for monocyte activation test kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i ...

This study covers the world outlook for systematic Lupus erythematosus treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share t ...

This study covers the world outlook for systemic Lupus erythematosus (SLE) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share th ...

This study covers the world outlook for anti-inflammatory Lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i ...

This study covers the world outlook for intravenous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...

This study covers the world outlook for autoimmune disorder diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for autoimmune disease diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for autoimmune disease diagnostic consumables and assay kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ...

This study covers the world outlook for anti-inflammatory autoimmune disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent ...

This study covers the world outlook for guillain-Barre syndrome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the co ...